HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE

INTRODUCTION: Homocysteine is process-product of methionine demethylation. It has proatherogenic, prothrombotic, prooxidative, proapoptotic, osteoporotic, neurotoxic, neuroinflamatory, and neurodegenerative effects. Hyperhomocysteinemia correlates with C667T MTHFR mutation, decrease of folic acid an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mater Sociomed
Egile Nagusiak: Ibrahimagic, Omer C., Smajlovic, Dzevdet, Dostovic, Zikrija, Pasic, Zejneba, Kunic, Suljo, Iljazovic, Amra, Hajdarevic, Denisa Salihovic
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AVICENA, d.o.o., Sarajevo 2016
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034996/
https://ncbi.nlm.nih.gov/pubmed/27698607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5455/msm.2016.28.303-306
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak